checkAd

    DGAP-News  312  0 Kommentare XPhyto Therapeutics Corp.: XPhyto Completes Corporate Rebranding and Launches New Website - Seite 2

    XPhyto Therapeutics Corp.

    Hugh Rogers, CEO and Director

    Investor Inquiries:
    Mr. Knox Henderson
    T: 604-551-2360
    E: info@xphyto.com

    Media Inquiries:
    MC Services AG
    Julia Hofmann, Andreas Jungfer
    T: +49 89 210 228 0
    E: xphyto@mc-services.eu

    Forward looking statements

    This news release includes statements containing forward-looking information within the meaning of applicable Canadian securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "develop", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "potential", "propose" and other similar words, or statements that certain events or conditions "may" or "will" occur, and in this release include the statement regarding the Company's goal of building a successful diagnostic, drug delivery, and medical cannabis company. Forward-looking statements are only predictions based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements, including: that the Company may not succeed in developing a commercial product; that the sale of products may not be a viable business; that the Company may be unable to scale its business; product liability risks; product regulatory risk; general economic conditions; adverse industry events; future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; currency risks; competition; international risks; and other risks beyond the Company's control. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this news release.

    Seite 2 von 3


    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    DGAP-News XPhyto Therapeutics Corp.: XPhyto Completes Corporate Rebranding and Launches New Website - Seite 2 DGAP-News: XPhyto Therapeutics Corp. / Key word(s): Miscellaneous XPhyto Therapeutics Corp.: XPhyto Completes Corporate Rebranding and Launches New Website 04.03.2021 / 09:05 The issuer is solely responsible for the content of this announcement. …